Michel Berlan

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Physiology

Lipolysis

Anatomy

Chemicals & Drugs

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
de Glisezinski I; Larrouy D; Bajzova M; Koppo K; Polak J; Berlan M; Bulow J; Langin D; Marques M A; Crampes F; Lafontan M; Stich V
Adrenaline but not noradrenaline is a determinant of exercise-induced lipid mobilization in human subcutaneous adipose tissue.
Birkenfeld Andreas L; Budziarek Petra; Boschmann Michael; Moro Cedric; Adams Frauke; Franke Gabriele; Berlan Michel; Marques Marie A; Sweep Fred C G J; Luft Friedrich C; Lafontan Max; Jordan Jens
Atrial natriuretic peptide induces postprandial lipid oxidation in humans.
Moro Cedric; Pillard Fabien; de Glisezinski Isabelle; Klimcakova Eva; Crampes Francois; Thalamas Claire; Harant Isabelle; Marques Marie-Adeline; Lafontan Max; Berlan Michel
Exercise-induced lipid mobilization in subcutaneous adipose tissue is mainly related to natriuretic peptides in overweight men.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Michel Berlan (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: de Glisezinski I; Larrouy D; Bajzova M; Koppo K; Polak J; Berlan M; Bulow J; Langin D; Marques M A; Crampes F; Lafontan M; Stich V
Adrenaline but not noradrenaline is a determinant of exercise-induced lipid mobilization in human subcutaneous adipose tissue.
The Journal of physiology 2009;587(Pt 13):3393-404.
2008: Birkenfeld Andreas L; Budziarek Petra; Boschmann Michael; Moro Cedric; Adams Frauke; Franke Gabriele; Berlan Michel; Marques Marie A; Sweep Fred C G J; Luft Friedrich C; Lafontan Max; Jordan Jens
Atrial natriuretic peptide induces postprandial lipid oxidation in humans.
Diabetes 2008;57(12):3199-204.
2008: Moro Cedric; Pillard Fabien; de Glisezinski Isabelle; Klimcakova Eva; Crampes Francois; Thalamas Claire; Harant Isabelle; Marques Marie-Adeline; Lafontan Max; Berlan Michel
Exercise-induced lipid mobilization in subcutaneous adipose tissue is mainly related to natriuretic peptides in overweight men.
American journal of physiology. Endocrinology and metabolism 2008;295(2):E505-13.
2008: Lafontan Max; Moro Cédric; Berlan Michel; Crampes François; Sengenes Coralie; Galitzky Jean
Control of lipolysis by natriuretic peptides and cyclic GMP.
Trends in endocrinology and metabolism: TEM 2008;19(4):130-7.
2007: Moro C; Klimcakova E; Lafontan M; Berlan M; Galitzky J
Phosphodiesterase-5A and neutral endopeptidase activities in human adipocytes do not control atrial natriuretic peptide-mediated lipolysis.
British journal of pharmacology 2007;152(7):1102-10.
2007: Polak Jan; Moro Cédric; Bessière David; Hejnova Jindra; Marquès Marie A; Bajzova Magda; Lafontan Max; Crampes Francois; Berlan Michel; Stich Vladimir
Acute exposure to long-chain fatty acids impairs {alpha}2-adrenergic receptor-mediated antilipolysis in human adipose tissue.
Journal of lipid research 2007;48(10):2236-46.
2007: Pillard Fabien; Moro Cédric; Harant Isabelle; Garrigue Eric; Lafontan Max; Berlan Michel; Crampes François; de Glisezinski Isabelle; Rivière Daniel
Lipid oxidation according to intensity and exercise duration in overweight men and women.
Obesity (Silver Spring, Md.) 2007;15(9):2256-62.
2007: Moro Cédric; Pillard Fabien; de Glisezinski Isabelle; Crampes François; Thalamas Claire; Harant Isabelle; Marques Marie-Adeline; Lafontan Max; Berlan Michel
Sex differences in lipolysis-regulating mechanisms in overweight subjects: effect of exercise intensity.
Obesity (Silver Spring, Md.) 2007;15(9):2245-55.
2007: Moro Cédric; Pillard Fabien; de Glisezinski Isabelle; Crampes Francois; Thalamas Claire; Harant Isabelle; Marques Marie-Adeline; Lafontan Max; Berlan Michel
Atrial natriuretic peptide contribution to lipid mobilization and utilization during head-down bed rest in humans.
American journal of physiology. Regulatory, integrative and comparative physiology 2007;293(2):R612-7.
2007: Polak J; Moro C; Klimcakova E; Kovacikova M; Bajzova M; Vitkova M; Kovacova Z; Sotornik R; Berlan M; Viguerie N; Langin D; Stich V
The atrial natriuretic peptide- and catecholamine-induced lipolysis and expression of related genes in adipose tissue in hypothyroid and hyperthyroid patients.
American journal of physiology. Endocrinology and metabolism 2007;293(1):E246-51.
2007: Moro C; Klimcakova E; Lolmède K; Berlan M; Lafontan M; Stich V; Bouloumié A; Galitzky J; Arner P; Langin D
Atrial natriuretic peptide inhibits the production of adipokines and cytokines linked to inflammation and insulin resistance in human subcutaneous adipose tissue.
Diabetologia 2007;50(5):1038-47.
2006: Birkenfeld Andreas L; Boschmann Michael; Moro Cedric; Adams Frauke; Heusser Karsten; Tank Jens; Diedrich André; Schroeder Christoph; Franke Gabi; Berlan Michel; Luft Friedrich C; Lafontan Max; Jordan Jens
Beta-adrenergic and atrial natriuretic peptide interactions on human cardiovascular and metabolic regulation.
The Journal of clinical endocrinology and metabolism 2006;91(12):5069-75.
2006: Klimcakova E; Polak J; Moro C; Hejnova J; Majercik M; Viguerie N; Berlan M; Langin D; Stich V
Dynamic strength training improves insulin sensitivity without altering plasma levels and gene expression of adipokines in subcutaneous adipose tissue in obese men.
The Journal of clinical endocrinology and metabolism 2006;91(12):5107-12.
2006: Polak Jan; Klimcakova Eva; Moro Cedric; Viguerie Nathalie; Berlan Michel; Hejnova Jindriska; Richterova Blanka; Kraus Ivan; Langin Dominique; Stich Vladimir
Effect of aerobic training on plasma levels and subcutaneous abdominal adipose tissue gene expression of adiponectin, leptin, interleukin 6, and tumor necrosis factor alpha in obese women.
Metabolism: clinical and experimental 2006;55(10):1375-81.
2006: Moro Cédric; Polak Jan; Hejnova Jindra; Klimcakova Eva; Crampes François; Stich Vladimir; Lafontan Max; Berlan Michel
Atrial natriuretic peptide stimulates lipid mobilization during repeated bouts of endurance exercise.
American journal of physiology. Endocrinology and metabolism 2006;290(5):E864-9.
2006: Moro Cédric; Berlan Michel
Cardiovascular and metabolic effects of natriuretic peptides.
Fundamental & clinical pharmacology 2006;20(1):41-9.
2006: Moro Cédric; Berlan Michel; Lafontan Max
[Physiological and pathophysiological features of the control of lipolysis and lipid mobilization by natriuretic peptides]
Journal de la Société de biologie 2006;200(1):67-76.
2005: Sengenes Coralie; Moro Cédric; Galitzky Jean; Berlan Michel; Lafontan Max
[Natriuretic peptides: a new lipolytic pathway in human fat cells]
Médecine sciences : M/S 2005;21 Spec No():29-33.
2005: Polak J; Moro C; Klimcakova E; Hejnova J; Majercik M; Viguerie N; Langin D; Lafontan M; Stich V; Berlan M
Dynamic strength training improves insulin sensitivity and functional balance between adrenergic alpha 2A and beta pathways in subcutaneous adipose tissue of obese subjects.
Diabetologia 2005;48(12):2631-40.
2005: Lafontan Max; Moro Cédric; Sengenes Coralie; Galitzky Jean; Crampes François; Berlan Michel
An unsuspected metabolic role for atrial natriuretic peptides: the control of lipolysis, lipid mobilization, and systemic nonesterified fatty acids levels in humans.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(10):2032-42.
2005: Moro Cedric; Pillard Fabien; De Glisezinski Isabelle; Harant Isabelle; Rivière Daniel; Stich Vladimir; Lafontan Max; Crampes François; Berlan Michel
Training enhances ANP lipid-mobilizing action in adipose tissue of overweight men.
Medicine and science in sports and exercise 2005;37(7):1126-32.
2005: Birkenfeld Andreas L; Boschmann Michael; Moro Cedric; Adams Frauke; Heusser Karsten; Franke Gabriele; Berlan Michel; Luft Friedrich C; Lafontan Max; Jordan Jens
Lipid mobilization with physiological atrial natriuretic peptide concentrations in humans.
The Journal of clinical endocrinology and metabolism 2005;90(6):3622-8.
2005: Sengenes Coralie; Moro Cédric; Galitzky Jean; Berlan Michel; Lafontan Max
[Natriuretic peptides: a new lipolytic pathway in human fat cells]
Médecine sciences : M/S 2005;21(1):61-5.
2005: Moro Cédric; Polak Jan; Richterova Blanka; Sengenès Coralie; Pelikanova Terezie; Galitzky Jean; Stich Vladimir; Lafontan Max; Berlan Michel
Differential regulation of atrial natriuretic peptide- and adrenergic receptor-dependent lipolytic pathways in human adipose tissue.
Metabolism: clinical and experimental 2005;54(1):122-31.
2004: Stich V; Berlan M
Physiological regulation of NEFA availability: lipolysis pathway.
The Proceedings of the Nutrition Society 2004;63(2):369-74.
2004: Moro Cedric; Crampes Francois; Sengenes Coralie; De Glisezinski Isabelle; Galitzky Jean; Thalamas Claire; Lafontan Max; Berlan Michel
Atrial natriuretic peptide contributes to physiological control of lipid mobilization in humans.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2004;18(7):908-10.
2004: Richterova B; Stich V; Moro C; Polak J; Klimcakova E; Majercik M; Harant I; Viguerie N; Crampes F; Langin D; Lafontan M; Berlan M
Effect of endurance training on adrenergic control of lipolysis in adipose tissue of obese women.
The Journal of clinical endocrinology and metabolism 2004;89(3):1325-31.
2004: Moro Cedric; Galitzky Jean; Sengenes Coralie; Crampes François; Lafontan Max; Berlan Michel
Functional and pharmacological characterization of the natriuretic peptide-dependent lipolytic pathway in human fat cells.
The Journal of pharmacology and experimental therapeutics 2004;308(3):984-92.
2003: Sengenes Coralie; Bouloumie Anne; Hauner Hans; Berlan Michel; Busse Rudi; Lafontan Max; Galitzky Jean
Involvement of a cGMP-dependent pathway in the natriuretic peptide-mediated hormone-sensitive lipase phosphorylation in human adipocytes.
The Journal of biological chemistry 2003;278(49):48617-26.
2003: de Glisezinski I; Moro C; Pillard F; Marion-Latard F; Harant I; Meste M; Berlan M; Crampes F; Rivière D
Aerobic training improves exercise-induced lipolysis in SCAT and lipid utilization in overweight men.
American journal of physiology. Endocrinology and metabolism 2003;285(5):E984-90.
2003: Stich Vladimir; Pelikanova Tereza; Wohl Petr; Sengenès Coralie; Zakaroff-Girard Alexia; Lafontan Max; Berlan Michel
Activation of alpha2-adrenergic receptors blunts epinephrine-induced lipolysis in subcutaneous adipose tissue during a hyperinsulinemic euglycemic clamp in men.
American journal of physiology. Endocrinology and metabolism 2003;285(3):E599-607.
2003: Lafontan Max; Berlan Michel
Do regional differences in adipocyte biology provide new pathophysiological insights?
Trends in pharmacological sciences 2003;24(6):276-83.
2003: Gesta S; Lolmède K; Daviaud D; Berlan M; Bouloumié A; Lafontan M; Valet P; Saulnier-Blache J S
Culture of human adipose tissue explants leads to profound alteration of adipocyte gene expression.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2003;35(3):158-63.
2003: Marion-Latard F; Crampes F; Zakaroff-Girard A; De Glisezinski I; Harant I; Stich V; Thalamas C; Rivière D; Lafontan M; Berlan M
Post-exercise increase of lipid oxidation after a moderate exercise bout in untrained healthy obese men.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2003;35(2):97-103.
2003: Crampes Francois; Marion-Latard Fabrice; Zakaroff-Girard Alexia; De Glisezinski Isabelle; Harant Isabelle; Thalamas Claire; Stich Vladimir; Rivière Daniel; Lafontan Max; Berlan Michel
Effects of a longitudinal training program on responses to exercise in overweight men.
Obesity research 2003;11(2):247-56.
2003: Pelat Michel; Verwaerde Patrick; Galitzky Jean; Lafontan Max; Berlan Michel; Senard Jean-Michel; Montastruc Jean-Louis
High isoproterenol doses are required to activate beta3-adrenoceptor-mediated functions in dogs.
The Journal of pharmacology and experimental therapeutics 2003;304(1):246-53.
2002: Suljkovicova Hana; Marion-Latard Fabrice; Hejnova Jindra; Majercik Marek; Crampes François; De Glisezinski Isabelle; Berlan Michel; Rivière Daniel; Stich Vladimir
Effect of macronutrient composition of the diet on the regulation of lipolysis in adipose tissue at rest and during exercise: microdialysis study.
Metabolism: clinical and experimental 2002;51(10):1291-7.
2002: Harant I; Marion-Latard F; Crampes F; de Glisezinski I; Berlan M; Stich V; Rivière D
Effect of a long-duration physical exercise on fat cell lipolytic responsiveness to adrenergic agents and insulin in obese men.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2002;26(10):1373-8.
2002: Berlan Michel; Verhaeghe Stephan; Pavy-Le Traon Anne; Thalamas Claire; Lafontan Max; Marques Marie Adeline; Senard Jean Michel; Parent Marc; Galitzky Jean
Yohimbine administration prevents over-responsiveness to epinephrine induced by simulated microgravity.
Aviation, space, and environmental medicine 2002;73(8):735-42.
2002: Sengenès Coralie; Zakaroff-Girard Alexia; Moulin Agnès; Berlan Michel; Bouloumié Anne; Lafontan Max; Galitzky Jean
Natriuretic peptide-dependent lipolysis in fat cells is a primate specificity.
American journal of physiology. Regulatory, integrative and comparative physiology 2002;283(1):R257-65.
2002: Lafontan M; Berlan M; Stich V; Crampes F; Rivière D; De Glisezinski I; Sengenes C; Galitzky J
Recent data on the regulation of lipolysis by catecholamines and natriuretic peptides.
Annales d'endocrinologie 2002;63(2 Pt 1):86-90.
2002: Stich V; Marion-Latard F; Hejnova J; Viguerie N; Lefort C; Suljkovicova H; Langin D; Lafontan M; Berlan M
Hypocaloric diet reduces exercise-induced alpha 2-adrenergic antilipolytic effect and alpha 2-adrenergic receptor mRNA levels in adipose tissue of obese women.
The Journal of clinical endocrinology and metabolism 2002;87(3):1274-81.
2002: Sengenes C; Stich V; Berlan M; Hejnova J; Lafontan M; Pariskova Z; Galitzky J
Increased lipolysis in adipose tissue and lipid mobilization to natriuretic peptides during low-calorie diet in obese women.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2002;26(1):24-32.
2001: Gesta S; Hejnova J; Berlan M; Daviaud D; Crampes F; Stich V; Valet P; Saulnier-Blache J S
In vitro and in vivo impairment of alpha2-adrenergic receptor-dependent antilipolysis by fatty acids in human adipose tissue.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2001;33(12):701-7.
2001: De Glisezinski I; Marion-Latard F; Crampes F; Berlan M; Hejnova J; Cottet-Emard J M; Stich V; Rivière D
Lack of alpha(2)-adrenergic antilipolytic effect during exercise in subcutaneous adipose tissue of trained men.
Journal of applied physiology (Bethesda, Md. : 1985) 2001;91(4):1760-5.
2001: Pelat M; Verwaerde P; Tran M A; Berlan M; Senard J M; Montastruc J L
Changes in vascular alpha 1- and alpha 2-adrenoceptor responsiveness by selegiline treatment.
Fundamental & clinical pharmacology 2001;15(4):239-45.
2001: Galitzky J; Sengenès C; Thalamas C; Marques M A; Senard J M; Lafontan M; Berlan M
The lipid-mobilizing effect of atrial natriuretic peptide is unrelated to sympathetic nervous system activation or obesity in young men.
Journal of lipid research 2001;42(4):536-44.
2001: Marion-Latard F; De Glisezinski I; Crampes F; Berlan M; Galitzky J; Suljkovicova H; Riviere D; Stich V
A single bout of exercise induces beta-adrenergic desensitization in human adipose tissue.
American journal of physiology. Regulatory, integrative and comparative physiology 2001;280(1):R166-73.
2000: Lafontan M; Berlan M; Galitzky J
[Lipid mobilization and energy metabolism: impact of molecular and cellular approaches on the treatment of obesity]
Annales d'endocrinologie 2000;61 Suppl 6():56-69.
2000: Lafontan M; Sengenes C; Galitzky J; Berlan M; De Glisezinski I; Crampes F; Stich V; Langin D; Barbe P; Rivière D
Recent developments on lipolysis regulation in humans and discovery of a new lipolytic pathway.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2000;24 Suppl 4():S47-52.
2000: Stich V; De Glisezinski I; Crampes F; Hejnova J; Cottet-Emard J M; Galitzky J; Lafontan M; Rivière D; Berlan M
Activation of alpha(2)-adrenergic receptors impairs exercise-induced lipolysis in SCAT of obese subjects.
American journal of physiology. Regulatory, integrative and comparative physiology 2000;279(2):R499-504.
2000: Sengenès C; Berlan M; De Glisezinski I; Lafontan M; Galitzky J
Natriuretic peptides: a new lipolytic pathway in human adipocytes.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2000;14(10):1345-51.
2000: Thalamas C; Galitzky J; Sénard J M; Lafontan M; Montastruc J L; Berlan M; Barbe P
Glucose-induced sympathetic activity and energy expenditure during acute alpha2-adrenergic antagonism in obese subjects.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2000;24(6):695-700.
2000: Stich V; de Glisezinski I; Berlan M; Bulow J; Galitzky J; Harant I; Suljkovicova H; Lafontan M; Rivière D; Crampes F
Adipose tissue lipolysis is increased during a repeated bout of aerobic exercise.
Journal of applied physiology (Bethesda, Md. : 1985) 2000;88(4):1277-83.
1999: Pelat M; Verwaerde P; Merial C; Galitzky J; Berlan M; Montastruc J L; Senard J M
Impaired atrial M(2)-cholinoceptor function in obesity-related hypertension.
Hypertension 1999;34(5):1066-72.
1999: Barbe P; Galitzky J; Thalamas C; Langin D; Lafontan M; Senard J M; Berlan M
Increase in epinephrine-induced responsiveness during microgravity simulated by head-down bed rest in humans.
Journal of applied physiology (Bethesda, Md. : 1985) 1999;87(5):1614-20.
1999: Stich V; de Glisezinski I; Crampes F; Suljkovicova H; Galitzky J; Riviere D; Hejnova J; Lafontan M; Berlan M
Activation of antilipolytic alpha(2)-adrenergic receptors by epinephrine during exercise in human adipose tissue.
The American journal of physiology 1999;277(4 Pt 2):R1076-83.
1999: Verwaerde P; Sénard J M; Galinier M; Rougé P; Massabuau P; Galitzky J; Berlan M; Lafontan M; Montastruc J L
Changes in short-term variability of blood pressure and heart rate during the development of obesity-associated hypertension in high-fat fed dogs.
Journal of hypertension 1999;17(8):1135-43.
1999: Carpéné C; Galitzky J; Fontana E; Atgié C; Lafontan M; Berlan M
Selective activation of beta3-adrenoceptors by octopamine: comparative studies in mammalian fat cells.
Naunyn-Schmiedeberg's archives of pharmacology 1999;359(4):310-21.
1999: Stich V; de Glisezinski I; Galitzky J; Hejnova J; Crampes F; Rivière D; Berlan M
Endurance training increases the beta-adrenergic lipolytic response in subcutaneous adipose tissue in obese subjects.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1999;23(4):374-81.
1999: Bousquet-Mélou A; Muñoz C; Galitzky J; Berlan M; Lafontan M
Pregnancy modifies the alpha2-beta-adrenergic receptor functional balance in rabbit fat cells.
Journal of lipid research 1999;40(2):267-74.
1999: Montastruc J L; Verwaerde P; Pelat M; Galitzky J; Langin D; Lafontan M; Berlan M
Peripheral cardiovascular actions of SR 58611 A, a beta 3-adrenoceptor agonist, in the dog: lack of central effect.
Fundamental & clinical pharmacology 1999;13(2):180-6.
1998: De Glisezinski I; Crampes F; Harant I; Berlan M; Hejnova J; Langin D; Rivière D; Stich V
Endurance training changes in lipolytic responsiveness of obese adipose tissue.
The American journal of physiology 1998;275(6 Pt 1):E951-6.
1998: Pelat M; Verwaerde P; Lazartiques E; Cabrol P; Galitzky J; Berlan M; Montastruc J L; Senard J M
[Twenty-four hour time and frequency domain variability of systolic blood pressure and heart rate in an experimental model of arterial hypertension plus obesity]
Archives des maladies du coeur et des vaisseaux 1998;91(8):999-1002.
1998: Barbe P; Millet L; Larrouy D; Galitzky J; Berlan M; Louvet J P; Langin D
Uncoupling protein-2 messenger ribonucleic acid expression during very-low-calorie diet in obese premenopausal women.
The Journal of clinical endocrinology and metabolism 1998;83(7):2450-3.
1998: Millet L; Barbe P; Lafontan M; Berlan M; Galitzky J
Catecholamine effects on lipolysis and blood flow in human abdominal and femoral adipose tissue.
Journal of applied physiology (Bethesda, Md. : 1985) 1998;85(1):181-8.
1998: Carpéné C; Bousquet-Mélou A; Galitzky J; Berlan M; Lafontan M
Lipolytic effects of beta 1-, beta 2-, and beta 3-adrenergic agonists in white adipose tissue of mammals.
Annals of the New York Academy of Sciences 1998;839():186-9.
1998: Barbe P; Galitzky J; De Glisezinski I; Riviere D; Thalamas C; Senard J M; Crampes F; Lafontan M; Berlan M
Simulated microgravity increases beta-adrenergic lipolysis in human adipose tissue.
The Journal of clinical endocrinology and metabolism 1998;83(2):619-25.
1998: Lafontan M; Betuing S; Saulnier-Blache J S; Valet P; Bouloumié A; Carpéné C; Galitzky J; Berlan M
Regulation of fat-cell function by alpha 2-adrenergic receptors.
Advances in pharmacology (San Diego, Calif.) 1998;42():496-8.
1997: Galitzky J; Langin D; Verwaerde P; Montastruc J L; Lafontan M; Berlan M
Lipolytic effects of conventional beta 3-adrenoceptor agonists and of CGP 12,177 in rat and human fat cells: preliminary pharmacological evidence for a putative beta 4-adrenoceptor.
British journal of pharmacology 1997;122(6):1244-50.
1997: Lafontan M; Barbe P; Galitzky J; Tavernier G; Langin D; Carpéné C; Bousquet-Melou A; Berlan M
Adrenergic regulation of adipocyte metabolism.
Human reproduction (Oxford, England) 1997;12 Suppl 1():6-20.
1997: Verwaerde P; Galinier M; Fourcade J; Massabuau P; Galitzky J; Senard J M; Tran M A; Berlan M; Montastruc J L
[Autonomic nervous system abnormalities in the initial phase of insulin resistance syndrome. Value of the study of variability of cardiac rate and blood pressure on a model of nutritional obesity]
Archives des maladies du coeur et des vaisseaux 1997;90(8):1151-4.
1997: Massabuau P; Verwaerde P; Galinier M; Fourcade J; Rougé P; Galitzky J; Senard J M; Berlan M; Bounhoure J P; Montastruc J L
[Left ventricular repercussion of obesity-induced arterial hypertension in the dog]
Archives des maladies du coeur et des vaisseaux 1997;90(8):1033-5.
1997: Stich V; Harant I; De Glisezinski I; Crampes F; Berlan M; Kunesova M; Hainer V; Dauzats M; Rivière D; Garrigues M; Holm C; Lafontan M; Langin D
Adipose tissue lipolysis and hormone-sensitive lipase expression during very-low-calorie diet in obese female identical twins.
The Journal of clinical endocrinology and metabolism 1997;82(3):739-44.
1997: Barbe P; Stich V; Galitzky J; Kunesova M; Hainer V; Lafontan M; Berlan M
In vivo increase in beta-adrenergic lipolytic response in subcutaneous adipose tissue of obese subjects submitted to a hypocaloric diet.
The Journal of clinical endocrinology and metabolism 1997;82(1):63-9.
1997: Bagheri H; Schmitt L; Berlan M; Montastruc J L
A comparative study of the effects of yohimbine and anetholtrithione on salivary secretion in depressed patients treated with psychotropic drugs.
European journal of clinical pharmacology 1997;52(5):339-42.
1996: Verwaerde P; Galinier M; Rougé P; Massabuau P; Galitzky J; Sénard J M; Berlan M; Montastruc J L
[Experimental hypertension induced by hypercaloric diet]
Archives des maladies du coeur et des vaisseaux 1996;89(8):1019-23.
1996: Barbe P; Millet L; Galitzky J; Lafontan M; Berlan M
In situ assessment of the role of the beta 1-, beta 2- and beta 3-adrenoceptors in the control of lipolysis and nutritive blood flow in human subcutaneous adipose tissue.
British journal of pharmacology 1996;117(5):907-13.
1996: Tavernier G; Barbe P; Galitzky J; Berlan M; Caput D; Lafontan M; Langin D
Expression of beta3-adrenoceptors with low lipolytic action in human subcutaneous white adipocytes.
Journal of lipid research 1996;37(1):87-97.
1996: Viguerie-Bascands N; Bousquet-Mélou A; Galitzky J; Larrouy D; Ricquier D; Berlan M; Casteilla L
Evidence for numerous brown adipocytes lacking functional beta 3-adrenoceptors in fat pads from nonhuman primates.
The Journal of clinical endocrinology and metabolism 1996;81(1):368-75.
1995: Lafontan M; Berlan M
Fat cell alpha 2-adrenoceptors: the regulation of fat cell function and lipolysis.
Endocrine reviews 1995;16(6):716-38.
1995: Lafontan M; Bousquet-Melou A; Galitzky J; Barbe P; Carpéné C; Langin D; Berlan M; Valet P; Castan I; Bouloumié A
Adrenergic receptors and fat cells: differential recruitment by physiological amines and homologous regulation.
Obesity research 1995;3 Suppl 4():507S-514S.
1995: Bousquet-Mélou A; Galitzky J; Moreno C M; Berlan M; Lafontan M
Desensitization of beta-adrenergic responses in adipocytes involves receptor subtypes and cAMP phosphodiesterase.
European journal of pharmacology 1995;289(2):235-47.
1995: Bousquet-Mélou A; Galitzky J; Lafontan M; Berlan M
Control of lipolysis in intra-abdominal fat cells of nonhuman primates: comparison with humans.
Journal of lipid research 1995;36(3):451-61.
1995: Galitzky J; Carpéné C; Bousquet-Mélou A; Berlan M; Lafontan M
Differential activation of beta 1-, beta 2- and beta 3-adrenoceptors by catecholamines in white and brown adipocytes.
Fundamental & clinical pharmacology 1995;9(4):324-31.
1995: Berlan M; Barbe P; Stich V; Galitzky J; Bousquet-Mélou A; Lafontan M
[Lipid mobilization, physiopathological and pharmacological aspects]
Annales d'endocrinologie 1995;56(2):97-100.
1995: Bagheri H; Chale J J; Guyen L N; Tran M A; Berlan M; Montastruc J L
Evidence for activation of both adrenergic and cholinergic nervous pathways by yohimbine, an alpha 2-adrenoceptor antagonist.
Fundamental & clinical pharmacology 1995;9(3):248-54.
1995: Berlan M; Galitzky J; Montastruc J L
Beta 3-adrenoceptors in the cardiovascular system.
Fundamental & clinical pharmacology 1995;9(3):234-9.
1994: Bousquet-Mélou A; Galitzky J; Carpéné C; Lafontan M; Berlan M
beta-Adrenergic control of lipolysis in primate white fat cells: a comparative study with nonprimate mammals.
The American journal of physiology 1994;267(1 Pt 2):R115-23.
1994: Berlan M; Galitzky J; Bousquet-Melou A; Lafontan M; Montastruc J L
Beta-3 adrenoceptor-mediated increase in cutaneous blood flow in the dog.
The Journal of pharmacology and experimental therapeutics 1994;268(3):1444-51.
1994: Bagheri H; Berlan M; Senard J M; Rascol O; Montastruc J L
Lacrimation in Parkinson's disease.
Clinical neuropharmacology 1994;17(1):89-91.
1994: Bagheri H; Picault P; Schmitt L; Houin G; Berlan M; Montastruc J L
Pharmacokinetic study of yohimbine and its pharmacodynamic effects on salivary secretion in patients treated with tricyclic antidepressants.
British journal of clinical pharmacology 1994;37(1):93-6.
1993: Montastruc J L; Galitzky J; Berlan M; Montastruc P
[Mechanism of receptor regulation during repeated administration of drugs]
Thérapie 1993;48(5):421-6.
1993: Barbe P; Galitzky J; Riviere D; Senard J M; Lafontan M; Garrigues M; Berlan M
Effects of physiological and pharmacological variation of sympathetic nervous system activity on plasma non-esterified fatty acid concentrations in man.
British journal of clinical pharmacology 1993;36(1):25-30.
1993: Lafontan M; Berlan M
Fat cell adrenergic receptors and the control of white and brown fat cell function.
Journal of lipid research 1993;34(7):1057-91.
1993: Galitzky J; Reverte M; Carpene C; Lafontan M; Berlan M
Beta 3-adrenoceptors in dog adipose tissue: studies on their involvement in the lipomobilizing effect of catecholamines.
The Journal of pharmacology and experimental therapeutics 1993;266(1):358-66.
1993: Galitzky J; Reverte M; Portillo M; Carpéné C; Lafontan M; Berlan M
Coexistence of beta 1-, beta 2-, and beta 3-adrenoceptors in dog fat cells and their differential activation by catecholamines.
The American journal of physiology 1993;264(3 Pt 1):E403-12.
1993: Senard J M; Rascol O; Durrieu G; Tran M A; Berlan M; Rascol A; Montastruc J L
Effects of yohimbine on plasma catecholamine levels in orthostatic hypotension related to Parkinson disease or multiple system atrophy.
Clinical neuropharmacology 1993;16(1):70-6.
1993: Galitzky J; Carpene C; Lafontan M; Berlan M
[Specific stimulation of adipose tissue adrenergic beta 3 receptors by octopamine]
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1993;316(5):519-23.
1992: Bagheri H; Schmitt L; Berlan M; Montastruc J L
Effect of 3 weeks treatment with yohimbine on salivary secretion in healthy volunteers and in depressed patients treated with tricyclic antidepressants.
British journal of clinical pharmacology 1992;34(6):555-8.
1992: Tavernier G; Galitzky J; Bousquet-Melou A; Montastruc J L; Berlan M
The positive chronotropic effect induced by BRL 37344 and CGP 12177, two beta-3 adrenergic agonists, does not involve cardiac beta adrenoceptors but baroreflex mechanisms.
The Journal of pharmacology and experimental therapeutics 1992;263(3):1083-90.
1992: Poncet M F; Damase-Michel C; Tavernier G; Tran M A; Berlan M; Montastruc J L; Montastruc P
Changes in plasma catecholamine and neuropeptide Y levels after sympathetic activation in dogs.
British journal of pharmacology 1992;105(1):181-3.
1992: Lafontan M; Berlan M; Galitzky J; Montastruc J L
Alpha-2 adrenoceptors in lipolysis: alpha 2 antagonists and lipid-mobilizing strategies.
The American journal of clinical nutrition 1992;55(1 Suppl):219S-227S.
1991: Galitzky J; Vermorel M; Lafontan M; Montastruc P; Berlan M
Thermogenic and lipolytic effect of yohimbine in the dog.
British journal of pharmacology 1991;104(2):514-8.
1991: Portillo M; Reverte M; Langin D; Senard J M; Tran M A; Berlan M; Montastruc J L
Effect of a 7-day treatment with idazoxan and its 2-methoxy derivative RX 821002 [correction of RX 821001] on alpha 2-adrenoceptors and non-adrenoceptor idazoxan binding sites in rabbits.
British journal of pharmacology 1991;104(1):190-4.
1991: Poncet M F; Tavernier G; Damase-Michel C; Tran M A; Berlan M; Montastruc J L; Montastruc P
[Neuropeptide Y, orthosympathetic nervous system, hypertension and alpha-2 adrenergic receptors]
Archives des maladies du coeur et des vaisseaux 1991;84(8):1239-41.
1991: Berlan M; Galitzky J; Riviere D; Foureau M; Tran M A; Flores R; Louvet J P; Houin G; Lafontan M
Plasma catecholamine levels and lipid mobilization induced by yohimbine in obese and non-obese women.
International journal of obesity 1991;15(5):305-15.
1991: Senard J M; Durrieu G; Berlan M; Estan L; Valet P; Tran M A; Garrigues M; Montastruc J L
Absence of arterial hypertension despite chronic plasma noradrenaline elevation: evidence for down-regulation of alpha-adrenoceptors. A case report.
Fundamental & clinical pharmacology 1991;5(4):291-8.
1990: Durrieu G; Rispail Y; Chatelut E; Berlan M; Rascol A; Montastruc J L; Montastruc P
Beta-adrenergic sensitivity in Parkinson's disease: effect of levodopa treatment.
Clinical neuropharmacology 1990;13(6):492-9.
1990: Senard J M; Valet P; Durrieu G; Berlan M; Tran M A; Montastruc J L; Rascol A; Montastruc P
Adrenergic supersensitivity in parkinsonians with orthostatic hypotension.
European journal of clinical investigation 1990;20(6):613-9.
1990: Estan L; Senard J M; Tran M A; Montastruc J L; Berlan M
Reserpine induces vascular alpha 2-adrenergic supersensitivity and platelet alpha 2-adrenoceptor up-regulation in dog.
British journal of pharmacology 1990;101(2):329-36.
1990: Galitzky J; Senard J M; Lafontan M; Stillings M; Montastruc J L; Berlan M
Identification of human platelet alpha 2-adrenoceptors with a new antagonist [3H]-RX821002, a 2-methoxy derivative of idazoxan.
British journal of pharmacology 1990;100(4):862-6.
1990: Senard J M; Barbe P; Estan L; Guimbaud R; Louvet J P; Berlan M; Tran M A; Montastruc J L
Decreased high affinity state in platelet alpha 2-adrenoceptors from diabetic patients with orthostatic hypotension.
The Journal of clinical endocrinology and metabolism 1990;71(2):311-7.
1990: Colomes M; Rispail Y; Berlan M; Pous J; Montastruc J L
[Drug consumption in a retired population]
Thérapie 1990;45(4):321-4.
1990: Barbe P; Senard J M; Estan L; Berlan M; Tran M A; Louvet J P; Montastruc J L
[Platelet alpha 2 adrenergic receptors, plasma catecholamines and orthostatic hypotension in insulin-dependent diabetic patients]
Archives des maladies du coeur et des vaisseaux 1990;83(8):1245-8.
1990: Durrieu G; Valet P; Berlan M; Villeneuve A; Montastruc J L
Levodopa up-regulates platelet alpha 2-adrenoceptors.
European journal of pharmacology 1990;182(3):597-601.
1990: Valet P; Berlan M; Beauville M; Crampes F; Montastruc J L; Lafontan M
Neuropeptide Y and peptide YY inhibit lipolysis in human and dog fat cells through a pertussis toxin-sensitive G protein.
The Journal of clinical investigation 1990;85(1):291-5.
1990: Galitzky J; Larrouy D; Berlan M; Lafontan M
New tools for human fat cell alpha-2A adrenoceptor characterization. Identification on membranes and on intact cells using the new antagonist [3H]RX821002.
The Journal of pharmacology and experimental therapeutics 1990;252(1):312-9.
1990: Rispail Y; Schmitt L; Berlan M; Montastruc J L; Montastruc P
Yohimbine increases salivary secretion in depressed patients treated with tricyclic antidepressants.
European journal of clinical pharmacology 1990;39(4):425-6.
1990: Galitzky J; Rivière D; Tran M A; Montastruc J L; Berlan M
Pharmacodynamic effects of chronic yohimbine treatment in healthy volunteers.
European journal of clinical pharmacology 1990;39(5):447-51.
1989: Saulnier-Blache J S; Taouis M; Dauzats M; Uzan A; Berlan M; Lafontan M
Lipolytic action of a new alpha-2 adrenergic antagonist of the piperazinopyrimidine family: RP 55462.
The Journal of pharmacology and experimental therapeutics 1989;251(3):1187-92.
1989: Saulnier-Blache J S; Taouis M; Dauzats M; Uzan A; Berlan M; Lafontan M
Mechanism of lipolytic action of a new alpha-2 adrenergic antagonist of the piperazinopyrimidine family: RP 55462.
The Journal of pharmacology and experimental therapeutics 1989;251(3):1193-8.
1989: Montastruc P; Berlan M; Montastruc J L
Effects of yohimbine on submaxillary salivation in dogs.
British journal of pharmacology 1989;98(1):101-4.
1989: Chatelut E; Rispail Y; Berlan M; Montastruc J L
Yohimbine increases human salivary secretion.
British journal of clinical pharmacology 1989;28(3):366-8.
1989: Taosis M; Valet P; Estan L; Lafontan M; Montastruc P; Berlan M
Obesity modifies the adrenergic status of dog adipose tissue.
The Journal of pharmacology and experimental therapeutics 1989;250(3):1061-6.
1989: Galitzky J; Lafontan M; Paris H; Berlan M
Human fat cell alpha-2 adrenoceptors. II. Comparative study of partial and full agonist binding parameters using [3H]clonidine and [3H]UK-14,304.
The Journal of pharmacology and experimental therapeutics 1989;249(2):592-600.
1989: Galitzky J; Mauriege P; Berlan M; Lafontan M
Human fat cell alpha-2 adrenoceptors. I. Functional exploration and pharmacological definition with selected alpha-2 agonists and antagonists.
The Journal of pharmacology and experimental therapeutics 1989;249(2):583-91.
1989: Valet P; Taouis M; Tran M A; Montastruc P; Lafontan M; Berlan M
Lipomobilizing effects of procaterol and yohimbine in the conscious dog: comparison of endocrinological, metabolic and cardiovascular effects.
British journal of pharmacology 1989;97(1):229-39.
1989: Berlan M; Rascol O; Belin J; Moatti J P; Rascol A; Montastruc J L
Alpha 2-adrenergic sensitivity in Parkinson's disease.
Clinical neuropharmacology 1989;12(2):138-44.
1989: Valet P; Montastruc J L; Berlan M; Tran M A; Lafontan M; Montastruc P
Differential regulation of fat cell beta-2 and beta-1 adrenoceptors by endogenous catecholamines in dog.
The Journal of pharmacology and experimental therapeutics 1989;249(1):271-7.
1989: Crampes F; Marceron M; Beauville M; Riviere D; Garrigues M; Berlan M; Lafontan M
Platelet alpha 2-adrenoceptors and adrenergic adipose tissue responsiveness after moderate hypocaloric diet in obese subjects.
International journal of obesity 1989;13(1):99-110.
1988: Galitzky J; Taouis M; Berlan M; Rivière D; Garrigues M; Lafontan M
Alpha 2-antagonist compounds and lipid mobilization: evidence for a lipid mobilizing effect of oral yohimbine in healthy male volunteers.
European journal of clinical investigation 1988;18(6):587-94.
1988: Taouis M; Berlan M; Montastruc P; Lafontan M
Mechanism of the lipid-mobilizing effect of alpha-2 adrenergic antagonists in the dog.
The Journal of pharmacology and experimental therapeutics 1988;247(3):1172-80.
1988: Mauriège P; De Pergola G; Berlan M; Lafontan M
Human fat cell beta-adrenergic receptors: beta-agonist-dependent lipolytic responses and characterization of beta-adrenergic binding sites on human fat cell membranes with highly selective beta 1-antagonists.
Journal of lipid research 1988;29(5):587-601.
1988: Lafontan M; Berlan M; Prud'Hon M
[Beta adrenergic agonists. Mechanisms of action: lipid mobilization and anabolism]
Reproduction, nutrition, development 1988;28(1):61-84.
1987: Taouis M; Berlan M; Montastruc P; Lafontan M
Characterization of dog fat cell adrenoceptors: variations in alpha-2 and beta adrenergic receptors distribution according to the extent of the fat deposits and the anatomical location.
The Journal of pharmacology and experimental therapeutics 1987;242(3):1041-9.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Michel Berlan

Research Profile (preview)

Physiology

Anatomy

Chemicals & Drugs

Disorders

Living Beings

Activities & Behaviors

Procedures

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Michel Berlan (preview)

All Publications